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Background: The presenting features and clinical course of biomass smoke induced bronchial
anthracofibrosis (BAF) are not well known.
Patients and methods: 333 patients who had a history of long-term exposure to biomass
smoke, having BAF confirmed by a bronchoscopy from January 1998 to December 2004, were
included in this study. The clinical features, associated diseases, and clinical outcomes were
investigated through the analysis of medical records.
Results: There were 51 males (15.3%) and 282 females (84.7%), having a mean age of 72.3 years,
ranging from 47 to 90. 33% of patients had a past history of pulmonary tuberculosis. Dyspnea
(38.4%) and cough (29.8%) were most common presenting symptoms, followed by hemoptysis
(8.9%). Baseline pulmonary function showed mild airflow obstruction. Among patients with
forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC)< 0.7, Global Initiative for
Chronic Obstructive Lung Disease (GOLD) stages I and II were most common. Associated diseases
were active tuberculosis in 33.9% of patients, pneumonia in 29.5%, acute exacerbation of chronic
airways disease in 22.5%, and malignancy in 4.8%. Among the 18 patients who died at a hospital
during the follow-up period, acute infection and malignancy were common causes of death.
Conclusions: These findings suggest that biomass smoke induced BAF usually appears clinically
as a form of obstructive airways disease. Since various pulmonary diseases, including tubercu-
losis, pneumonia, and malignancy, can be associated with BAF, thorough clinical evaluation
and close follow-up of these patients are required.
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Bronchial anthracofibrosis (BAF) is characterized by
a bronchoscopic finding of multiple dark anthracotic
pigmentations on large airway mucosa with or without
bronchial narrowing or obliteration.1 In Korea, it is usually
found in patients with chronic obstructive pulmonary
disease (COPD) or bronchial asthma which does not respond
well to the general treatments, but also in patients with
abnormal radiographic findings and no symptoms.1e4
Anthracotic pigmentations are considered to be mostly the
result of carbon particle deposition but iron, lead,
cadmium, silica, phenol, hydrocarbon complexes, and
other inorganic or organic substances also can cause this
pigmentation.5e7 These pigmentations can be frequently
observed in patients with no environmental exposure to
coal dust or smoking. The epidemiologic, clinical, and
bronchoscopic findings of BAF are different from those of
coal worker’s pneumoconiosis, which is characterized by
carbon particle deposition in peripheral airways or paren-
chyma causing pulmonary fibrosis.8 Tuberculosis, which has
been prevalent in Korea, has been posited to be the main
causative factor of BAF.1,3,9
Most BAF patients in Korea have been females of an old
age, who have had no history of smoking. They often
resided in traditional Korean rural housing where the
kitchen had been the place for both cooking and heating
using biomass fuels, such as wood, leaves, and crop resi-
dues. Ventilation equipment was often inadequate.2e4
Such epidemiologic characteristics and bronchoscopic
findings are not markedly different from studies reported
in other countries.10,11 Moreover, most BAF patients in
Korea have had no past medical history of tuberculosis and
often did not have active tuberculosis at the time of
diagnosis.2e4,12 Therefore, it was recently suggested that
factors other than tuberculosis are responsible for the
development of BAF, and the long-term exposure to
biomass smoke, mainly wood smoke, is one of them.3,4,12,13
In developing nations, biomass fuels are used extensively
for home heating and cooking.14 Epidemiologic studies15e26
show that cooking smoke appears to increase the risk of
chronic lung diseases. However, bronchial manifestation
related to biomass smoke and its clinical features are not
well known. Although this disease is rare in developed
countries, some cases of BAF have been reported among
immigrants to North America from developing countries
where biomass had been used as a fuel.27,28 The aim of this
study was to clarify the presenting features and clinical
course of biomass smoke induced BAF from the description
of the clinical, functional, bronchoscopic, radiographic
findings and outcome in a group of patients with this
disease.
Materials and methods
Among a total of 2883 patients who underwent bronchos-
copy from January 1998 to December 2004 at our seven-
hundred bed referral hospital, 333 patients found to have
BAF were included in this study. The clinical characteristics
and associated diseases at the time of bronchoscopy were
investigated through retrospective analysis of medicalrecords. The patient follow-up data were obtained until
December 2006. We were unable to ascertain a patient’s
death if it occurred at home or at another hospital. We,
instead, analyzed follow-up rate. We also analyzed causes
of death of 18 patients who died at our hospital during
follow-up period. All diagnostic procedures were per-
formed for patients with informed consent, and the study
protocol was approved by the Hospital Institutional Review
Board.
BAF was considered present when multiple dark
pigmentations were seen on the bronchial mucosa. When
either the lumen of pigmented lobar or segmental bronchi
was narrower than normal bronchus or when they showed
complete obliteration, bronchial stenosis was described.
Patients showing only a single pigmented spot without
bronchial stenosis were excluded. In every patient, speci-
mens acquired through bronchial washing were evaluated on
both smear and culture for acid-fast bacilli and evaluated for
cancer by cytology. Bronchial biopsy was performed when
indicated. Spirometry (Vmax 229, SensorMedics, Yorba
Linda, CA, USA) was performed according to the American
Thoracic Society Guidelines29 when the patient was in
a clinically stable state after the initial chief complaint was
improved by treatment. We were only able to obtain post-
bronchodilator spirometry in 151 patients (45.3%), usually
because of advanced age or patient refusal. Predicted values
according to Crapo et al30 were used. To describe the
severity of airflow obstruction, we used Global Initiative for
Chronic Obstructive Lung Disease (GOLD) criteria.31 The
duration of exposure to the wood smoke was estimated as
being from the beginning of the patient’s time of cooking and
heating in traditional Korean rural housing environment to
the time at which changes in living environment, type of fuel
or retirement occurred.
Associated diseases were defined as follows: in the
case of documentation of acid-fast bacilli from the
sputum or bronchial washing, or histological finding
consistent with tuberculosis, or improvement by empirical
anti-tuberculous medication in a patient with active
radiological finding, diagnosis of active tuberculosis was
made. Malignancy was diagnosed when malignant cells
were shown on cytology from the sputum or bronchial
washing, or when definite malignant features were shown
from histology, or when chest CT showed definite malig-
nant features. The patient who showed clinical symptoms
of infection with infiltrates on chest radiography but
lacked the evidence of tuberculosis or lung cancer was
diagnosed as having pneumonia. Without the evidence of
above diseases, the patient who showed obstructive
ventilatory mechanics on pulmonary function testing, or
others who did not undergo pulmonary function test but
had consistent physical findings and past medical history
of obstructive pulmonary disease, were diagnosed as
exacerbation of obstructive airways disease. In addition,
in patients with acute bronchitis or upper respiratory
tract infection and who had nonspecific radiological find-
ings and/or normal pulmonary function, BAF alone was
diagnosed.
Data are reported as mean SD or number (%). The
follow-up rate of patients was estimated by the Kaplane
Meier method and was compared with the log rank-test
(Sigmastat, V 3.11, San Jose, CA).
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Epidemiologic and clinical characteristics
The mean age of patients was 72.3, ranging from 47 to 90
years. The subject group consisted of 51 males (15.3%) and
282 females (84.7%). There were 260 non-smokers (78.1%)
and 73 smokers (21.9%). All patients had a history of
exposure to wood smoke; 52 patients could verify the
duration of exposure, ranging from 12 to 60 years (mean,
36.1 years). All female patients were housewives who had
been living in a traditional Korean rural housing environ-
ment. All male patients were farmers; none had worked in
the mining industry. 110 patients (33.0%) had a past history
of tuberculosis. Dyspnea (38.4%) and cough (29.8%) were
most common presenting symptoms, followed by hemop-
tysis (8.9%). 23 patients (6.8%) had no specific pulmonary
symptoms but abnormal findings on chest radiology. In 151
patients with spirometry, forced vital capacity (FVC),
forced expiratory volume in 1 s (FEV1) and FEV1/FVC were
90.8 22.1% predicted, 83.9 22.2% predicted, and
68.8 11.4%, respectively. Among 79 patients (52.3%) with
FEV1/FVC< 0.7, GOLD I and II were most common, 28/79
patients (35.4%) and 43/79 patients (54.4%), respectively
(Table 1).Table 1 Epidemiologic and clinical characteristics
(nZ 333)*.
Characteristics Values
Age (yr) 72.3 6.24 (47e90)
Male/Female (n, %) 51/282 (15.3/84.7)
Smoker/Nonsmoker (n, %) 73/260 (21.9/78.1)
Verified duration of wood
smoke exposure (nZ 52, yr)
36.1 11.43 (12e60)
History of past tuberculosis (n, %) 110 (33.0)
Chief complaint (n, %)
Dyspnea 128 (38.4)
Cough 199 (29.8)
Hemoptysis 30 (8.9)
Fever 20 (6.0)
Sputum 5 (1.5)
X-ray abnormality 23 (6.8)
Others 28 (8.3)
Spirometry (nZ 151)
FVC, % predicted 90.8 22.09
FEV1, % predicted 83.9 22.22
FEV1/FVC, % 68.8 11.40
GOLD stage in case with
FEV1/FVC< 0.7 (nZ 79)
I FEV1 80% predicted (n, %) 28 (35.4)
II 50% FEV1< 80% predicted
(n, %)
43 (54.4)
III 30% FEV1< 50% predicted
(n, %)
7 (8.9)
IV FEV1< 30% predicted (n, %) 1 (1.3)
*Values are given as the mean SD, unless otherwise indicated.
GOLDZGlobal Initiative for Chronic Obstructive Lung Disease.Bronchoscopic findings
The principal finding was multiple pigmented lesions and
bronchial stenosis (Fig. 1). Pigment was found most
frequently on the mucosa around the branching points of
the bronchus, particularly in both upper lobes; right upper
lobe in 302 patients (90.7%) and left upper lobe in 289
patients (86.8%). Bronchial stenosis was found at the inlet
of lobar or segmental bronchi along with pigments and was
observed in 308 patients (92.5%). More than one part of the
bronchial tree was narrowed in 232 patients (69.1%). Nar-
rowing was found most frequently in the right middle lobe
and right upper lobe, in 229 patients (68.8%) and 213
patients (64.0%), respectively. Two commonly associated
conditions were endobronchial tuberculosis and tumor.
Endobronchial tuberculosis was observed in 40 patients
(12.0%), most frequently in the right middle lobar bronchus,
and tumor was found in 12 patients (3.6%) (Table 2).
Bronchoscopic biopsy was performed in 62 patients,
resulting in 31 patients with tuberculosis, 27 patients with
chronic nonspecific inflammation, and 4 patients with
carcinoma. Bleeding was the most common complication
during or after biopsy, but in no case did it have serious
consequences.
Chest CT findings
Upon chest CT, bronchial narrowing, atelectasis, and
enlargement of calcified or non-calcified lymph nodes were
the most common findings (Table 3). In 206 patients
(81.7%), bronchial narrowing or atelectasis was found.
Among them, 48 patients (19.0%) had atelectasis without
bronchial narrowing whereas 53 patients (21.0%) had
bronchial narrowing without atelectasis. 105 patients
(41.7%) had both atelectasis and bronchial narrowing. 166
patients (65.9%) showed multiple lymph node enlarge-
ments, which were calcified in 112 patients and non-calci-
fied in 54 patients. Two other associated lesions were
parenchymal and pleural abnormalities. In 182 patients
(72.2%), parenchymal abnormalities were found and
included consolidation, interstitial infiltration, inactive
tuberculous lesion, and mass. Pleural abnormalities were
observed in 62 patients (24.6%).
Associated diseases
Two most common associated diseases were active tuber-
culosis and pneumonia, in 113 patients (33.9%) and 98
patients (29.5%), respectively (Table 4). Among tubercu-
losis patients, endobronchial tuberculosis was observed in
40 patients (12.0%). 75 patients (22.5%) were diagnosed as
having an acute exacerbation of obstructive airways
disease. Among them, 56 patients (16.8%) showed clinical
features of chronic obstructive pulmonary disease and 19
patients (5.7%) showed that of bronchial asthma. 16
patients (4.8%) had malignancy, including lung cancer in 15
patients and metastasis from colon cancer in 1 patient. The
types of lung cancer were 5 adenocarcinoma, 2 squamous
cell carcinoma, 1 small cell carcinoma, and 3 carcinoma
types undetermined. The other 4 patients were diagnosed
clinically due to their extreme age or patient’s refusal to
Figure 1 Bronchoscopic finding of 80 year-old woman who has a history of long-term exposure to biomass smoke shows multiple
dark anthracotic pigmentations on large airway mucosa with bronchial narrowing of RUL and RML. RUL, right upper lobar bronchus;
RM, right main bronchus; RML, right middle lobar bronchus, RLL, right lower lobar bronchus; LUL, left upper lobar bronchus; LLL,
left lower lobar bronchus.
760 Y.J. Kim et al.invasive procedure. 29 patients (8.6%) had no specific
associated disease.
Follow-up data
53 patients were transferred to another primary hospital or
were lost to follow-up. We were able to assess the follow-
up data in 280 patients for a period ranging from 7 days to
2788 days. There was a statistically significant difference
among all the follow-up rate curves (p< 0.001), but noTable 2 Bronchoscopic findings of bronchial anthracofibrosis (n
RUL RML RLL
Main lesions
Pigment 302 (90.7) 253 (80.0) 201 (60.4)
Stenosis 213 (64.0) 229 (68.8) 120 (36.0)
Combined lesions
ETB 10 (3.0) 16 (4.8) 1 (0.3)
Tumor 5 (1.5) 2 (0.6) 3 (0.9)
Values are given as number (%).
RUL, right upper lobar bronchus; RML, right middle lobar bronchus; RL
left lower lobar bronchus; RM, right main bronchus; LM, left main brsignificant differences were shown among the patients with
tuberculosis, pneumonia, and acute exacerbation of
obstructive airways disease. No patient with malignancy
had a follow-up period as long as 4 years (Fig. 2). The
causes of death in 18 patients who died at our hospital
during the follow-up period were malignancy in 6 cases,
acute infection in 5 cases, cardiac disease in 3 cases,
trauma in 2 cases, acute exacerbation of obstructive
airways disease in 1 case, and massive hemoptysis in 1 case
(Table 5).Z 333).
LUL LLL RM LM
289 (86.8) 210 (62.8) 73 (21.9) 56 (16.8)
173 (51.9) 104 (31.2) e e
10 (3.0) 1 (0.3) 1 (0.3) 1 (0.3)
2 (0.6) 0 (0.0) e e
L, right lower lobar bronchus; LUL, left upper lobar bronchus; LLL,
onchus; ETB, endobronchial tuberculosis.
Table 3 Chest CT findings in patients with bronchial
anthracofibrosis (nZ 252).
Findings Number (%)
Bronchial narrowing 53 (21.0)
Atelectasis 48 (19.0)
Atelectasis and bronchial narrowing 105 (41.7)
Lymph node enlargement, multiple 166 (65.9)
Calcified 112 (44.5)
Non-calcified 54 (21.4)
Parenchymal abnormality 182 (72.2)
Pleural abnormality 62 (24.6)
Tuberculosis (n=96)
Pneumonia (n=85)
AEOAD (n=60)
BAF only (n=25)
Malignancy (n=12)
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Figure 2 Follow-up rate in patients with bronchial anthra-
cofibrosis according to the associated disease. There was
a statistically significant difference among all the follow-up
rate curves (p< 0.001), but no significant differences were
shown among the first three associated diseases. AEOAD, acute
exacerbation of obstructive airways disease.
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Clinical phenotype and relation with pulmonary
tuberculosis
In this study, most of the patients with BAF were older
female non-smokers who had long-term exposure to wood
smoke and whose baseline pulmonary function showed
a mild airflow obstruction. Most patients with airflow
obstruction (defined as FEV1/FVC< 0.7) were GOLD stages
1 and 2. Sandoval et al.10 described the clinical charac-
teristics of a group of 30 nonsmoking women with wood
smoke inhalation-associated lung disease (WSIALD). They
observed BAF-like features in 14 of 22 patients with bron-
choscopy. On the pulmonary function test, inconsistent
with our study, the patients showed a mixed restrictivee
obstructive pattern. This is because all the subjects have
a pulmonary arterial hypertension with cor pulmonale andTable 4 Associated diseases in patients with bronchial
anthracofibrosis (nZ 333).
Disease Number (%)
Active tuberculosis 113 (33.9)
Pneumonia 98 (29.5)
AEOAD
COPD 56 (16.8)
Bronchial asthma 19 (5.7)
Malignancy
Lung cancera 15 (4.5)
Adenocarcinoma 5 (1.5)
Squamous cell carcinoma 2 (0.6)
Small cell carcinoma 1 (0.3)
Carcinoma type undetermined 3 (0.9)
Metastasis from colon cancer 1 (0.3)
Others 2 (0.6)
BAF only 29 (8.7)
a 4 patients were diagnosed clinically due to their extreme
age or patient’s refusal to invasive procedure. AEOADZ acute
exacerbation of obstructive airways disease, COPDZ chronic
obstructive pulmonary disease, BAFZ bronchial
anthracofibrosis.represent the more deteriorated, and selected group of
people suffering WSIALD. In Korea, as in the case of this
study, the most common abnormality of the ventilatory
function in BAF is an obstructive pattern.3,4,12,32 Although
the use of fixed ratio of FEV1/FVC< 0.7 may result in over
diagnosis of chronic obstructive pulmonary disease in
milder patients who are elderly,31,33 BAF patients without
associated disease are usually classified as having chronicTable 5 In-hospital causes of death in patients with
bronchial anthracofibrosis during follow-up (nZ 18).
Cause of death Number Associated disease
at first diagnosis
Infection
Pneumonia 4 2 TB, 1 Pneumonia, 1 Lung
cancer
Sepsis 1 1 BAF only
Malignancy
Lung cancer 4 4 Lung cancer
Ovarian cancer 1 1 TB
Colon cancer 1 1 Pneumonia
Cardiac disease
Heart failure 2 1 TB, 1 Pneumonia
AMI 1 1 TB
Trauma 2 1 TB, 1 Bronchial asthma
AEOAD 1 1 AEOAD
Massive hemoptysis 1 1 Pneumonia
TB, tuberculosis; BAF, bronchial anthracofibrosis; AMI, acute
myocardial infarction; AEOAD, acute exacerbation of obstruc-
tive airways disease.
762 Y.J. Kim et al.airways disease and are treated in different ways according
to their presenting symptoms.2-4,12,13 In fact, prolonged
inhalation of wood smoke may cause chronic pulmonary
diseases.15e22 Wood smoke exposure is an independent risk
factor for obstructive airways disease and an earlier and
longer time of exposure will increase the development of
obstructive airways disease.18,21 In addition, exposure to
cooking smoke is strongly associated with the prevalence of
asthma in the elderly and the effect is greater for women
than for men.22 Seen from this point of view, it thus seems
clear that biomass smoke induced BAF usually appears
clinically as a form of obstructive airways disease.
The rate of past medical history of tuberculosis ranges
from 13 to 25% and active tuberculosis ranges from 39 to 61%
in patients with BAF reported in Korea1e3; in our series it was
33.0% and 33.9%, respectively. Recently, Han et al.12
concluded that chemotherapy for tuberculosis should be
administrated only with bacteriologic confirmation in
patients with BAF. In addition, cooking smoke can increase
the risk of tuberculosis.23,24 Therefore, it is strongly sus-
pected from these considerations that tuberculosis is only an
associated disease with BAF, and is not causative. Although
some patients with endobronchial tuberculosis originated
from mediastinal tuberculous lymphadenitis were observed
to have pigmentation,34,35 this pathologic feature is usually
localized to one bronchus, particularly right middle lobar
bronchus in contrast to the multiple locations observed in
BAF. In our series, all the patients with endobronchial
tuberculosis had no clinical evidence of tuberculous lymph-
adenitis and had multiple pigmentations scattered in both
lungs. Although the reason for the high prevalence of
tuberculosis in patients with BAF is not clearly defined,
increase in sensitivity to Mycobacterium tuberculosis due to
silica contained in pigmentations,36 increase in prevalence
of tuberculosis related to old age,37 and change in pulmonary
immune defensemechanism due to toxic substances in wood
smoke14 are plausibly responsible factors.
Bronchoscopic findings
Biomass smoke, particularly wood smoke, is a complex
mixture of numerous gases and respirable particles of
varying inorganic or organic composition and diameter.14
The mechanisms by which carbonaceous particles are
deposited can be explained as follows: (1) in the process of
removing inhaled particles, macrophages in the airway
engulf the particles and remain in the submucosa,38 (2)
inhaled particles that are not quickly cleared by normal
mucociliary clearance or by macrophages are directly taken
up by bronchial epithelial cells.39 The particles that are
inhaled into bronchus are mostly accumulated at the
branching portion of bronchus by inertial impaction39 and
there is a relatively lower clearance rate of this portion of
the bronchial tree as compared to other parts.40,41 Deposited
carbonaceous particles give rise to fibrosis of the bronchial
wall or surrounding interstitium which may cause hyper-
trophy of the bronchial wall and luminal narrowing.13,39 In
our series, as was reported by Sandoval et al.,10 pigmenta-
tion was found most frequently in both upper lobar bronchi
and were mainly distributed around the branching portion of
the bronchus. In most patients, bronchial stenosis was found
in the inlet of lobar or segmental bronchi accompanied bypigmentations. Particularly, both bronchial stenosis and
associated endobronchial tuberculosis were observed most
commonly in right middle lobar bronchus. This may in part
related to a relatively more rapid pathologic process of BAF
in the right middle lobar bronchus which has more
surrounding lymph nodes and narrower lumen than other
parts of the lungs. Consequently, it is hypothesized that
acid-fast bacilli can easily implant at this site because of
a compromise of the local immune defense mechanism.14
Sometimes, inflamed pigmented mucosa is easily prone to
bleed.1,2 In our series, hemoptysis was observed in 8.9% of
patients and bleeding was the most common complication
during bronchoscopy. Since trivial contact or even suctioning
with negative pressure to inflamed mucosa can lead to
bleeding, all procedures should be done cautiously.
Chest CT findings
The characteristic primary finding is curvilinear bronchial
narrowing or atelectasis with enlargement of lymph nodes
which are usually calcified (Fig. 3).1,9 In our series, atelec-
tasis or bronchial narrowing was observed in 82% of patients
and enlarged lymph nodes were observed in 66%. Including
our series, in BAF patients who had enlarged lymph nodes,
57%e90% had calcification within the nodes.1e3,9 These
primary findings reflect the basic pathologic process of BAF
and are very diagnostic if they are observed on a chest CT in
elderly patients who have had long-term exposure of
biomass smoke.1,9 The mechanism for enlargements of
multiple lymph nodes with calcification can be explained as
follows: Inhaled carbon containing particles engulfed by
macrophages either enter the lymphatic system or promote
development of lymph tissues in lung. These carbon particle
depositions in lymph tissues increase as the exposure period
lengthens. In addition, silica in the biomass smoke can
induce fibrosis and form nodular hyaline scars in the lung
parenchyma or lymph nodes.38 However, secondary findings
on chest CT are observed variably including both paren-
chymal and pleural abnormalities, as determined by the
associated diseases.1,3,9 The most frequent active paren-
chymal abnormalities are consolidation, interstitial infiltra-
tion, and ground-glass attenuation. While most of the active
secondary findings clear with treatment of the associated
diseases,27 the primary findings appear to be nearly
unchanged. Simple chest radiography is nonspecific for the
diagnosis of BAF because most findings are secondary. As
a primary finding, atelectasis or calcified lymph nodes are
occasionally encountered.1,2
Clinical course
Most BAF patients are studied with bronchoscopy or chest
CT, performed in an attempt to investigate the underlying
cause when a patient is not responding to conventional
therapy, is having an unexpectedly poor clinical course
considering the associated disease, has persistent localized
wheezing, or presents with abnormal chest radiographic
findings without respiratory symptoms.2e4,12 In this study,
pulmonary infection, including tuberculosis and pneumonia,
and exacerbation of obstructive airways disease were the
two most commonly associated diseases. Lung cancer was
diagnosed between 4% and 17% of patients with BAF in
Figure 3 Chest computed tomography of 72 year-old (A) and 69 year-old (B) women with bronchial anthracofibrosis, both of
whom have a history of long-term exposure to biomass smoke, show bronchial narrowing (arrow on A), multiple calcified lymph
nodes (arrowhead on A and B), and atelectasis of right middle lobe (arrow on B). Associated active parenchymal (A) and pleural (B)
abnormalities are also shown.
Biomass smoke induced bronchial anthracofibrosis 763previous reports,2,3,12 and 4.5% in this study. Given the
report25,26 that domestic exposure to combustion of fuel
increases the risk of lung cancer, it is not surprising that lung
cancer in BAF patients also has a strong causal relationship
with long-term exposure to biomass smoke. However, it is
not clear that themain pathology of BAF is linkedwith cancer
development. The overall follow-up rates were notBr
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Figure 4 Clinical course in patients with biomass smoke induced
pulmonary disease.significantly different among patients with tuberculosis,
pneumonia, and acute exacerbation of obstructive airways
disease, because many patients with tuberculosis or pneu-
monia required monitoring of their underlying airways
disease after treatment. Excluding lung cancer patients who
were diagnosed at first presentation, most patients who died
did so from a disease other than the first associated disease,Chronic biomass
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Parenchymal disease
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bronchial anthracofibrosis in Korea. COPD, chronic obstructive
764 Y.J. Kim et al.and pneumonia was the most common disease among the
pulmonary causes of death. Given the fact that most of the
areas of pneumonic consolidation were seen in lobes with
bronchial narrowing,13 it seems clear that structural abnor-
mality of the bronchus is a major predisposing factor for the
development of pneumonia in patients with BAF. Pneumonia
or acute exacerbation of airways disease tends to occur
repeatedly during the clinical course of BAF.12
Conclusion
In conclusion, biomass smoke induced BAF has a character-
istic bronchoscopic and chest CT findings and usually
appears clinically as a form of obstructive airways disease.
Since various pulmonary diseases, including tuberculosis,
pneumonia, and malignancy, can be associated with BAF
(Fig. 4), thorough clinical evaluation and close follow-up of
patients are required.
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